FDA Targets Illegal Online Parmacies in Globally Coordinated Action
The U.S. Food and Drug Administration, in partnership with other federal and international
agencies, took action this week against websites that sell potentially dangerous, unapproved
prescription drugs to U.S. consumers. The FDA and the U.S. Customs and Border Protection (CBP) also
conducted extensive examinations at U.S.-based international mail facilities, where many packages
containing prescription drugs enter the U.S., and found that most of the examined packages
contained illegal prescription drugs that had been ordered from online sources.
These actions took place in support of the 7th annual International Internet Week of Action (IIWA)
— May 13 to May 20, 2014 — sponsored by Interpol, and also known as Operation Pangea VII. During
Operation Pangea VII, law enforcement, customs, and regulatory authorities from 111 countries
collaborated to identify the makers and distributors of illegal drug products and medical devices
that used the Internet to sell their products and remove these products from the supply chain.
Operation Pangea VII‘s coordinated efforts at mail facilities resulted in the detention or seizure
of 19,618 packages containing medicines purportedly from Australia, the United Kingdom (UK), New
Zealand and Canada. These packages actually contained unapproved or suspected counterfeit drugs
from other countries, such as India, China, Singapore, Taiwan, Mexico, Laos, Malaysia, as well as
Australia, New Zealand and the UK.
BeMedWise Program at NeedyMeds, formerly the National Council on Patient Information and Education (NCPIE), encourages healthcare professionals and community groups to foster patient–professional communication about medicines. However, BeMedWise does not supervise or endorse the activities of any group or professional. Discussion and action concerning medicines are solely the responsibility of the patient and their healthcare professionals, and not BeMedWise.
Please consult a licensed health care professional with questions or concerns about your medication and/or condition.